NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/12/2022
Voltar para busca
Dado oficial do USPTO
SYNE-CHF
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
06/12/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
11/10/2021
Data de registro
06/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/12/2022
Última transação
06/12/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Oxford, Oxfordshire, GB
Examinador
GREEN, ASHLEY ELIZABETH
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Sensyne Health Group Limited
Representantes
Robert B.G. Horowitz, Esq. BAKER & HOSTETLER LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Recorded and downloadable computer software for use by the healthcare and life sciences business sectors for analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms
Classe 42
Designing and developing computer software containing algorithms for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment; Software as a Service (SAAS) services in the form of computer software for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms; Algorithms as a service (AAAS)on-linenon-downloadable software containing algorithms from a cloud-based platform for the design of computer software and computer programming for third-parties in the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/09/2022
PUBO
PUBLISHED FOR OPPOSITION
20/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
16/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
16/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2022
ALIE
ASSIGNED TO LIE
07/07/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/06/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
26/05/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
26/05/2022
CNSI
SUSPENSION INQUIRY WRITTEN
26/05/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
26/11/2021
GNSL
LETTER OF SUSPENSION E-MAILED
26/11/2021
CNSL
SUSPENSION LETTER WRITTEN
26/11/2021
DOCK
ASSIGNED TO EXAMINER
14/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2021
NWAP
NEW APPLICATION ENTERED
14/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYNE-CHF ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.